Health and Quality of Life Outcomes

Table 3 Multiple regression analyses mapping EORTC QLQ-C30 and EORTC QLQ-MY20 data to EQ-5D

From: Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma

Predictors	Full model		Trimmed model
	Estimate	p-value	Estimate	p-value
QLQ-C30
Intercept	0.11979	0.3757	0.25763	0.0002
Global health status/QoL*	0.00161	0.0568	0.00165	0.0301
Physical functioning*	0.00471	< 0.0001	0.00467	< 0.0001
Role functioning	0.00073194	0.3455	NS	NS
Emotional functioning	0.00104	0.2522	NS	NS
Cognitive functioning	−0.00037864	0.6203	NS	NS
Social functioning	0.00044712	0.4983	NS	NS
Fatigue	−0.00005750	0.9521	NS	NS
Nausea/Vomiting	0.00053330	0.7166	NS	NS
Pain*	−0.00229	0.0039	−0.00293	< 0.0001
Dyspnoea	0.00037610	0.5099	NS	NS
Insomnia*	0.00096618	0.0570	0.00089197	0.0616
Appetite loss	−0.00047987	0.4899	NS	NS
Constipation	−0.00055193	0.3057	NS	NS
Financial difficulties	0.00096199	0.0613	NS	NS
QLQ-MY20
Disease symptoms	−0.00094431	0.3983	NS	NS
Side effects	0.00207	0.1445	NS	NS
Future perspective*	0.00149	0.0366	0.00157	0.0061
Body image	−0.00040870	0.4607	NS	NS
Adjusted R-squared values	0.7015		0.7028
RMSE indices	0.164		0.163

*Significant predictors in the full model.
NS not significant.

Back to article page

ISSN: 1477-7525

Contact us

Submission enquiries: journalsubmissions@springernature.com